Lyra Therapeutics reported total assets of $36.11M and total liabilities of $46.83M for the quarter ended Dec 2025, down 45.6% year over year. This balance sheet covers 28 quarters of results from Mar 2019 through Dec 2025, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accumulated Depreciation | 2.95M | 3.25M | 3.60M | 3.88M | 4.16M | 4.45M | 4.72M | 4.17M | 1.92M | 2.20M | 2.24M | 4.13M | 4.26M | 4.34M | 4.45M | 4.55M | ||||||||||||
| Assets | ||||||||||||||||||||||||||||
| Current Assets | ||||||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 66.11M | 69.05M | 58.13M | 46.08M | 34.08M | 122.09M | 110.98M | 33.94M | 23.41M | 55.75M | 26.24M | 23.75M | 17.79M | 33.90M | 25.79M | 40.58M | 31.73M | 29.80M | 22.10M | 15.90M | ||||||||
| Receivables - OtherOther Receivables | ||||||||||||||||||||||||||||
| Prepaid Assets | 1.25M | 1.03M | 2.75M | 2.17M | 1.80M | 1.38M | 2.34M | 2.94M | 2.09M | 1.80M | 2.37M | 2.07M | 2.33M | 1.94M | 2.82M | 2.45M | 2.17M | 1.28M | 0.96M | 0.38M | ||||||||
| Current Assets | 67.35M | 70.07M | 60.89M | 47.92M | 40.55M | 122.38M | 112.23M | 100.83M | 84.80M | 118.25M | 104.92M | 104.82M | 89.44M | 69.44M | 54.44M | 43.02M | 33.91M | 31.06M | 23.02M | 16.27M | ||||||||
| Non-Current Assets | ||||||||||||||||||||||||||||
| Property, Plant & Equipment (Net) | 3.17M | 3.85M | 4.71M | 4.50M | 4.28M | 4.01M | 3.75M | 2.24M | 2.00M | 0.56M | 0.73M | 2.04M | 3.78M | 1.67M | 1.61M | 1.40M | 1.28M | 1.16M | 1.12M | 1.05M | ||||||||
| Other Non-Current Assets | 0.33M | 0.33M | 0.33M | 0.76M | 1.08M | 1.70M | 1.78M | 3.30M | 3.85M | 4.35M | 7.46M | 1.39M | 1.99M | 1.99M | 1.99M | 1.99M | 1.99M | 1.99M | 1.99M | 1.99M | ||||||||
| Non-Current Assets | 5.57M | 6.26M | 6.88M | 6.95M | 6.79M | 7.65M | 7.23M | 9.14M | 9.07M | 7.42M | 15.65M | 37.78M | 52.08M | 25.15M | 24.31M | 23.32M | 22.41M | 21.51M | 20.69M | 19.84M | ||||||||
| Assets | 72.92M | 76.33M | 67.76M | 54.87M | 47.34M | 130.03M | 119.46M | 109.97M | 93.87M | 125.67M | 120.58M | 142.60M | 141.53M | 94.58M | 78.76M | 66.35M | 56.32M | 52.57M | 43.71M | 36.11M | ||||||||
| Liabilities | ||||||||||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||||||||||
| Accounts Payables | 1.17M | 1.90M | 2.91M | 3.12M | 2.41M | 1.67M | 2.90M | 2.62M | 3.95M | 4.19M | 5.05M | 3.13M | 2.84M | 4.97M | 2.29M | 1.18M | 0.72M | 0.68M | 0.63M | 0.66M | ||||||||
| Payables | 1.17M | 1.90M | 2.91M | 3.12M | 2.41M | 1.67M | 2.90M | 2.62M | 3.95M | 4.19M | 5.05M | 3.13M | 2.84M | 4.97M | 2.29M | 1.18M | 0.72M | 0.68M | 0.63M | 0.66M | ||||||||
| Accumulated Expenses | 1.99M | 2.98M | 3.97M | 4.26M | 4.24M | 5.46M | 7.32M | 9.03M | 6.79M | 6.74M | 11.05M | 9.37M | 10.06M | 6.09M | 4.86M | 4.35M | 4.04M | 3.49M | 3.06M | 3.27M | ||||||||
| Other Accumulated Expenses | 0.06M | 0.07M | 0.13M | 0.63M | 0.04M | 0.12M | 0.30M | 0.66M | 1.23M | 0.47M | 0.52M | |||||||||||||||||
| Current Leases | 1.01M | 1.03M | 1.05M | 1.07M | 1.10M | 0.93M | 0.65M | 1.55M | 1.90M | 1.69M | 1.40M | 5.43M | 4.50M | 4.27M | 4.00M | 4.12M | 4.24M | 4.55M | 4.68M | 4.82M | ||||||||
| Current Deferred Revenue | 12.00M | 9.84M | 11.71M | 16.25M | 15.72M | 15.36M | 15.35M | 14.94M | 14.48M | 13.94M | 13.79M | 13.26M | 12.66M | 12.47M | 12.26M | 12.08M | 11.89M | 11.87M | 11.86M | |||||||||
| Total Current Liabilities | 4.17M | 5.90M | 17.77M | 18.25M | 21.96M | 10.61M | 13.61M | 14.47M | 14.15M | 14.11M | 19.23M | 19.60M | 18.72M | 19.28M | 14.95M | 12.63M | 11.47M | 11.16M | 9.48M | 9.52M | ||||||||
| Non-Current Liabilities | ||||||||||||||||||||||||||||
| Non-Current Deffered Revenue | 2.15M | 1.93M | 2.02M | 13.18M | 12.63M | 14.08M | 13.43M | 12.99M | 12.21M | 12.14M | 11.94M | 11.85M | 11.86M | 11.86M | 11.86M | 11.86M | 11.86M | 11.86M | ||||||||||
| Preferred Stock Liabilities | ||||||||||||||||||||||||||||
| Operating Leases | 1.20M | 0.93M | 0.66M | 0.38M | 0.10M | 0.00M | 0.00M | 0.67M | 0.19M | 4.89M | 21.45M | 33.36M | 32.48M | 31.32M | 30.26M | 29.11M | 27.93M | 26.70M | 25.44M | |||||||||
| Total Non-Current Liabilities | 5.37M | 18.83M | 20.57M | 20.55M | 24.09M | 23.79M | 29.21M | 27.10M | 36.34M | 53.18M | 64.02M | 63.60M | 58.14M | 54.75M | 52.44M | 50.95M | 48.04M | |||||||||||
| Total Liabilities | 5.37M | 18.83M | 20.57M | 20.55M | 24.09M | 23.79M | 26.24M | 29.21M | 27.78M | 27.10M | 36.34M | 53.18M | 64.02M | 63.60M | 58.14M | 54.75M | 52.44M | 50.95M | 48.04M | 46.83M | ||||||||
| Shareholder's Equity | ||||||||||||||||||||||||||||
| Common Equity | 67.55M | 57.50M | 47.19M | 34.32M | 23.26M | 106.25M | 93.22M | 80.75M | 66.09M | 98.58M | 84.24M | 89.42M | 77.50M | 30.98M | 20.62M | 11.59M | 3.87M | 1.62M | -4.33M | -10.72M | ||||||||
| Liabilities and Shareholders Equity | 72.92M | 76.33M | 67.76M | 54.87M | 47.34M | 130.03M | 119.46M | 109.97M | 93.87M | 125.67M | 120.58M | 142.60M | 141.53M | 94.58M | 78.76M | 66.35M | 56.32M | 52.57M | 43.71M | 36.11M | ||||||||
| Retained Earnings | -157.69M | -168.72M | -179.80M | -193.40M | -205.31M | -219.70M | -234.44M | -248.68M | -264.93M | -280.55M | -296.20M | -311.36M | -333.81M | -381.94M | -393.81M | -404.79M | -413.34M | -420.80M | -426.80M | -433.71M | ||||||||
| Treasury Shares |